Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Insider Analysis From Perkins Coie LLP: China IP Intelligence Briefing

This article was originally published in PharmAsia News

Executive Summary

ChinaIP Intelligence Briefing is a periodic PharmAsia News feature prepared by Perkins Coie LLP to summarize the status of major IP cases brought in China affecting the pharmaceutical industry. The first installment of this series appeared in July (PharmAsia News, July 17, 2008).

You may also be interested in...



Insider Analysis from Perkins Coie: China IP Intelligence Briefing

China IP Intelligence Briefing is a periodic PharmAsia News feature prepared by Perkins Coie LLP to summarize the status of major IP cases brought in China affecting the pharmaceutical industry. The last installment of this series appeared October 2008 (PharmaAsia News, Oct. 27, 2008).

Insider Analysis From Perkins Coie LLP: China IP Intelligence Briefing

China IP Intelligence Briefing is a new periodic PharmAsia News feature prepared by Perkins Coie LLP to summarize the status of major IP cases brought in China affecting the pharmaceutical industry.

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

OM013626

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel